title: Clinical protocol. Phase I trial to evaluate the safety of H5.020CMV.PDGF-b and limb compression bandage for the treatment of venous leg ulcer: trial A.
authors.affiliation: Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA 19102, USA.
authors.forename: David J
authors.initials: DJ
authors.lastname: Margolis
authors.forename: Timothy
authors.initials: T
authors.lastname: Cromblehome
authors.forename: Meenhard
authors.initials: M
authors.lastname: Herlyn
authors.forename: Philip
authors.initials: P
authors.lastname: Cross
authors.forename: Linda
authors.initials: L
authors.lastname: Weinberg
authors.forename: Jennifer
authors.initials: J
authors.lastname: Filip
authors.forename: Kathleen
authors.initials: K
authors.lastname: Propert
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D001458:Bandages; D000077214:Becaplermin; D002986:Clinical Trials as Topic; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D007249:Inflammation; D007866:Leg / Q000473:pathology; D007871:Leg Ulcer / Q000209:etiology / Q000628:therapy*; D010982:Platelet-Derived Growth Factor / Q000235:genetics / Q000378:metabolism; D011312:Pressure; D011446:Prospective Studies; D020574:Proto-Oncogene Proteins c-sis; D011817:Rabbits; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000378:metabolism; D014647:Varicose Ulcer / Q000473:pathology / Q000628:therapy*; D014945:Wound Healing
chemical_list: D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D000077214:Becaplermin; D020797:Receptor, Platelet-Derived Growth Factor beta